Semaglutide, a GLP-1 receptor agonist , is FDA-approved not only for type 2 diabetes but also for chronic weight management in adults who meet specific criteria
Sucralose and sugar alcohols (sorbitol, maltitol, mannitol) can cause bloating and diarrhea in sensitive individuals
Guidelines on the diagnosis and treatment of male infertility
When compounding in compliance with federal and state law, compounded drugs are not subject to FDA approval and are not evaluated for safety or efficacy
According to CMS, qualification requires a BMI of: BMI 35 with no additional clinical condition required , or BMI 30 with at least one of : heart failure, uncontrolled hypertension, or chronic kidney disease, or BMI 27 with at least one of : pre-diabetes, prior heart attack, prior stroke, or symptomatic peripheral artery disease